|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.2 USD | +0.33% |
|
+1.74% | +42.06% |
| 31/05 | Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target | MT |
| 21/05 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
Immunome, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 4.27 million compared to USD 11.65 million a year ago. Basic loss per share from continuing operations was USD 0.35 compared to USD 0.96 a year ago.
Diluted loss per share from continuing operations was USD 0.35 compared to USD 0.96 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +42.06% | 912M | |
| +18.72% | 125B | |
| +14.19% | 108B | |
| -4.93% | 24.21B | |
| +3.23% | 22.78B | |
| -10.44% | 17.96B | |
| -41.74% | 16.43B | |
| -13.31% | 16.37B | |
| +2.44% | 13.58B | |
| +27.89% | 11.66B |
IMMUNOME, INC. 
